Hebei Xingang Pharmaceutical Co Ltd

Hebei Xingang Pharmaceutical Co Ltd is located on the bank of the world-famous Zhaozhou Bridge – Zhaoxian Industrial Park, Shijiazhuang City, Hebei Province. It is adjacent to the Qingyin Expressway and National Highway 308 in the east, and the Beijing-Zhuhai Expressway and National Highway 107 in the west; it is 30 kilometers away from Shijiazhuang High-speed Railway Station and 50 kilometers away from Shijiazhuang International Airport. The company mainly engages in the research, development, production and sales of rifamycin biotechnology fermentation and pharmaceutical intermediates, APIs and related products. The main products are rifamycin S-Na salt, rifamycin S, 3-F, rifamycin SV sodium, rifampicin, rifapentine, rifaximin, rifabutin, rifaprodin and other rifamycin series products, as well as limonene and intermediates and more than ten varieties. It is one of the world’s major manufacturers of anti-tuberculosis APIs and rifamycin extended products.

Hebei Xingang Pharmaceutical Co., Ltd. was established in 1996. At the beginning of its establishment, the company clearly positioned its development goals: to strive to be the global leader in rifamycin series products and to devote itself to pursuing high-quality rifamycin series products. Under this goal orientation, the company firmly established the concept of “employee quality is the life of the enterprise, product quality is the global market”. Technical excellence stems from high morality. The high professional ethics of the company’s employees are the source of enterprise development. Xingang people are always full of vigorous spirit of pursuing excellence! They never stop self-cultivating noble sentiments! They cultivate their own lofty moral character with down-to-earth attitude! They always pursue and dedicate their excellent skills!

An excellent talent team creates high-quality products and promotes enterprise upgrading. The company has always placed product quality in the first place for global users’ peace of mind and comprehensively improved the quality assurance system. In 2004, the company introduced rifampicin and rifapentine APIs, and passed the Chinese GMP certification for the first time in the same year; in 2010, it passed the domestic GMP certification for the second time; in 2015, it successfully passed the new version of Chinese GMP certification.

The company has world-class production equipment and workshops, modern laboratories and testing facilities. The fermentation workshop has realized computer temperature control, automatic feeding, and fermentation equipment is closer to the international advanced level. The extraction workshop has been continuously advancing in the extraction process of rifamycin S sodium through continuous exploration and practice over the years, and product quality has been continuously improved. It not only improves production efficiency, improves production environment, but also improves product quality. The synthesis workshop has been updated with equipment and production line transformation. At present, it has two completely independent production lines, with separate human flow and material flow, effectively avoiding the risk of product confusion. The air conditioning pressure difference in the workshop clean area is automatically controlled by computer. Both lines are equipped with a fully enclosed vacuum feeding system, which greatly improves the working environment of workers, and fundamentally eliminates the intrusion of foreign objects, thereby greatly improving product quality. The newly purchased Atlas oil-free screw air compressor fundamentally eliminates the pollution caused by oil and water in compressed air to products.

Since its establishment, the company has always paid continuous attention and investment to R&D, and established long-term close contacts with many higher education institutions and scientific research institutions. The company was rated as a high-tech enterprise in 2012, and at the same time, the company’s technology center undertook a number of provincial and municipal scientific research projects in recent years, and achieved a number of scientific and technological achievements. The company adheres to the corporate development purpose of “the leader of rifamycin series products”, takes independent innovation as the source of enterprise development, continuously strengthens scientific and technological innovation, and promotes the transformation of achievements. The company has a domestic advanced microbial fermentation laboratory, which currently has three stainless steel fermentation tanks, one steam generator, as well as a self-control system and various modern testing instruments. The company’s R&D personnel have many years of laboratory R&D experience, and promote the comprehensive improvement of the company’s fermentation level through continuous optimization experiments on production strains. The company has always adhered to the corporate spirit of “product quality is the global market”, putting quality first. At present, the company has four laboratories, namely: fermentation central control room, synthesis central control room, east factory area laboratory and west factory area central laboratory.

All along, our company has pursued the concept of “enterprise development, environmental protection first”, and has made a lot of investment in environmental governance over the past ten years, providing a guarantee for the sustainable development of the enterprise. We always run through the concept of clean production throughout the production process, first of all, improve the system, conduct full staff training on clean production related knowledge, mobilize employees to brainstorm, actively propose improvement plans, and achieve “clean production, everyone is responsible”. All along, the company has been paying attention to the dynamics of environmental protection field, ready to introduce advanced environmental protection facilities.

The company relies on its good reputation, efficient management methods, excellent product quality, and has become the leader in the international market. The products meet the latest version standards of BP/EP/USP and other pharmacopoeias, which can meet the quality needs of global customers. The company has a professional international trade sales team that can provide the fastest feedback to domestic and foreign customers’ consultation audits and other requirements. The company’s products have been sold to dozens of countries and regions such as India, Pakistan, Indonesia, Philippines, Vietnam, Germany, Russia, Brazil, Chile, Africa, etc. It has established long-term good cooperative relations with internationally renowned formulation manufacturers of rifamycin series products at home and abroad.

Time flies by unconsciously. Hebei Xingang Pharmaceutical Co., Ltd. has gone through nearly 20 years. In these 20 years, Xingang Pharmaceutical has seized talents and every opportunity to gradually strengthen itself. At present, the company has become the leader in rifampicin API industry. It can be foreseen that the company’s products will have a broader market and the enterprise will enter a more benign cycle. On the road of production and development of rifamycin series products, Hebei Xingang Pharmaceutical Co., Ltd. will surely become a rising star.

 

error: Content is protected !!